Applied Clinical Trials
February 01, 2005
View from Washington
Concerns over risky medicines are shutting down clinical studies and boosting demand for comparative drug analysis.
February 01, 2005
Technology Viewpoint
Writing computer code isn?t as difficult as you might think.
February 01, 2005
Feature Article
Because it can take time to obtain independent EC or review board approval, the temptation to start a study without it can become strong.
February 01, 2005
Letters to the Editor
Readers respond to articles and commentaries.
February 01, 2005
A Closing Thought
In the biomedical research industry, and at Pfizer in particular, we are committed to what we call "The Three As"-making medicines available, accessible, and affordable.
February 01, 2005
View from Brussels
Industry?s proposal for a shared database has merit, but is it ?too little too late??
February 01, 2005
Feature Article
If the activity is a significant risk device study, surgeons must first obtain FDA and IRB approval.
February 01, 2005
Guest Editorial
Perhaps a way forward is to refocus our efforts on a "culture of conscience," since our conscience often guides our actions.
February 01, 2005
Feature Article
Our training places heavy emphasis on site selection: The entire study may suffer if sites are chosen poorly.
February 01, 2005
eShowcase
A new database design is behind a way of generating reports when you want them--such as right now
February 01, 2005
Feature Article
Most pharmaceutical companies place a high priority on reducing their costs to offset pressure on profit margins. They also struggle to accelerate the development of profitable new drugs: Based on drug sale statistics, pharmaceutical companies lose substantial revenue each day a new drug is delayed from reaching the market.